OSU MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.1M
- Transactions
- 130
- Companies
- 17
- Average per transaction
- $8,492
Who reported the payments
| Purdue Pharma L.p. | $831,416 |
| Clovis Oncology, Inc. | $90,718 |
| Angiodynamics, Inc. | $79,917 |
| Insulet Corporation | $37,450 |
| Stryker | $23,055 |
| Tandem Diabetes Care, Inc. | $20,225 |
| Acell, Inc. | $8,856 |
| Fresenius Kabi USA, LLC | $3,600 |
| KARL Storz Endoscopy-america | $2,850 |
| Fisher Scientific Company L.L.C. | $2,064 |
| Linde Gas & Equipment Inc. | $1,980 |
| Pfizer | $650 |
| Samsung HME America, Inc. | $552 |
| Qiagen, LLC | $329 |
| Siemens Medical Solutions USA, Inc. | $196 |
| Hikma Pharmaceuticals USA | $66 |
| Zimmer Biomet | $29 |